2-[4-(2-Nitrobenzenesulfonyl)piperazin-1-yl]pyrimidine

Catalog No. :
ACTTWE788
CAS No. :
545358-46-1
Molecular Formula :
C14H15N5O4S
Molecular Weight :
349.37

IUPAC Name:2-(4-((2-nitrophenyl)sulfonyl)piperazin-1-yl)pyrimidine

2-[4-(2-Nitrobenzenesulfonyl)piperazin-1-yl]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-[4-(2-Nitrobenzenesulfonyl)piperazin-1-yl]pyrimidine
IUPAC Name2-(4-((2-nitrophenyl)sulfonyl)piperazin-1-yl)pyrimidine
MDL No.MFCD01567382
Molecular FormulaC14H15N5O4S
Molecular Weight349.37
SMILESO=S(N1CCN(C2=NC=CC=N2)CC1)(C3=CC=CC=C3[N+]([O-])=O)=O
InChI KeyXETXFMSHLNWMDR-UHFFFAOYSA-N
Synonym2-{4-[(2-nitrophenyl)sulfonyl]piperazino}pyrimidine;2-[4-(2-nitrobenzenesulfonyl)piperazin-1-yl]pyrimidine;2-(4-((2-Nitrophenyl)sulfonyl)piperazin-1-yl)pyrimidine;Pyrimidine, 2-[4-[(2-nitrophenyl)sulfonyl]-1-piperazinyl]-
CAS No.545358-46-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTTWE788 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRKMW197 route compound structure diagram
    ACRKMW19778069-54-2 In Stock
  4. Then
  5. ACTTWE788 route product structure diagram
    ACTTWE788545358-46-1
Inquiry

2. ACTTWE788 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRKMW197 route compound structure diagram
    ACRKMW19778069-54-2 In Stock
  4. Then
  5. ACTTWE788 route product structure diagram
    ACTTWE788545358-46-1
Inquiry

Comments (0)